4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Zhiyong Qian, Jianghong Guo, Zhiyong Zhang, Yao Wang, Xiaofeng Hou, Jiangang Zou. Optimal programming management of ventricular tachycardia storm in ICD patients[J]. The Journal of Biomedical Research, 2015, 29(1): 35-43. DOI: 10.7555/JBR.29.20140146
Citation: Zhiyong Qian, Jianghong Guo, Zhiyong Zhang, Yao Wang, Xiaofeng Hou, Jiangang Zou. Optimal programming management of ventricular tachycardia storm in ICD patients[J]. The Journal of Biomedical Research, 2015, 29(1): 35-43. DOI: 10.7555/JBR.29.20140146

Optimal programming management of ventricular tachycardia storm in ICD patients

More Information
  • Received Date: November 05, 2014
  • Ventricular tachycardia storm (VTS) is defined as a life-threatening syndrome of three or more separate episodes of ventricular tachycardia (VT) leading to implantable cardioverter defibrillator (ICD) therapy within 24 hours. Patients with VTS have poor outcomes and require immediate medical attention. ICD shocks have been shown to be associated with increased mortality in several studies. Optimal programming in minimization of ICD shocks may decrease mortality. Large controlled trials showed that long detection time and high heart rate detection threshold reduced ICD shock burden without an increase in syncope or death. As a fundamental therapy of ICD, antitachycardia pacing (ATP) can terminate most slow VT with a low risk of acceleration. For fast VT, burst pacing is more effective and less likely to result in acceleration than ramp pacing. One algorithm of optimal programming management during a VTS is presented in the review.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Jiaqi Tang, Lin Luo, Bakwatanisa Bosco, Ning Li, Bin Huang, Rongrong Wu, Zihan Lin, Ming Hong, Wenjie Liu, Lingxiang Wu, Wei Wu, Mengyan Zhu, Quanzhong Liu, Peng Xia, Miao Yu, Diru Yao, Sali Lv, Ruohan Zhang, Wentao Liu, Qianghu Wang, Kening Li. Identification of cell surface markers for acute myeloid leukemia prognosis based on multi-model analysis[J]. The Journal of Biomedical Research, 2024, 38(4): 397-412. DOI: 10.7555/JBR.38.20240065
    [3]Liming Gou, Gang Yang, Sujuan Ma, Tong Ding, Luan Sun, Fang Liu, Jin Huang, Wei Gao. Galectin-14 promotes hepatocellular carcinoma tumor growth via enhancing heparan sulfate proteoglycan modification[J]. The Journal of Biomedical Research, 2023, 37(6): 418-430. DOI: 10.7555/JBR.37.20230085
    [4]Xiaochen Huang, Jiaojiao Guo, Tao Li, Lizhou Jia, Xiaojun Tang, Jin Zhu, Qi Tang, Zhenqing Feng. c-Met-targeted chimeric antigen receptor T cells inhibit hepatocellular carcinoma cells in vitro and in vivo[J]. The Journal of Biomedical Research, 2022, 36(1): 10-21. DOI: 10.7555/JBR.35.20200207
    [5]Chen Fei, Li Yuancheng, Qin Na, Wang Fengliang, Du Jiangbo, Wang Cheng, Du Fangzhi, Jiang Tao, Jiang Yue, Dai Juncheng, Hu Zhibin, Lu Cheng, Shen Hongbing. RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer[J]. The Journal of Biomedical Research, 2020, 34(2): 129-138. DOI: 10.7555/JBR.34.20190111
    [6]Long Xie, Heming Wu, Siyu Liu, Hongwei Li. Spindle cell carcinoma of the mandible: a case report[J]. The Journal of Biomedical Research, 2017, 31(3): 273-276. DOI: 10.7555/JBR.30.20140061
    [7]Li Liu, Yao Liu, Jibin Liu, Xiangjun Zhai, Juan Wen, Kaipeng Xie, Hongbing Shen, Zhibin Hu, Zhining Fan. Genetic variants in pseudogene E2F3P1 confer risk for HBV-related hepatocellular carcinoma in a Chinese population[J]. The Journal of Biomedical Research, 2013, 27(3): 215-219. DOI: 10.7555/JBR.27.20130019
    [8]Zhengshan Wu, Jianjie Qin, Liyong Pu. Omega-3 fatty acid improves the clinical outcome of hepatectomized patients with hepatitis B virus (HBV)-associated hepatocellular carcinoma[J]. The Journal of Biomedical Research, 2012, 26(6): 395-399. DOI: 10.7555/JBR.26.20120058
    [9]Xinting Pan, Liqun Wu, Jingyu Cao, Weidong Guo, Zusen Wang, Bing Han, Weiyu Hu. Recombinant adenovirus vector-mediated human MDA-7 gene transfection suppresses hepatocellular carcinoma growth in a mouse xenograft model[J]. The Journal of Biomedical Research, 2012, 26(1): 53-58. DOI: 10.1016/S1674-8301(12)60007-4
    [10]Chen Tao, Li Dan, Fuya ling, Gongzi Peng. In vivo and in vitro effects of QHF combined with chemotherapy on hepatocellular carcinoma[J]. The Journal of Biomedical Research, 2010, 24(2): 161-168.
  • Cited by

    Periodical cited type(9)

    1. Farjat-Pasos JI, Guedeney P, Horlick E, et al. Determinants of adverse outcomes following patent foramen ovale closure in elderly patients. EuroIntervention, 2024, 20(16): 1029-1038. DOI:10.4244/EIJ-D-24-00156
    2. Wu G, Wu J, Lu Q, et al. Association between cardiovascular risk factors and atrial fibrillation. Front Cardiovasc Med, 2023, 10: 1110424. DOI:10.3389/fcvm.2023.1110424
    3. Kim HL, Lee EM, Ahn SY, et al. The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension. Clin Hypertens, 2023, 29(1): 11. DOI:10.1186/s40885-023-00234-9
    4. Ma J, Chen Q, Ma S. Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management. J Cell Mol Med, 2021, 25(6): 2764-2775. DOI:10.1111/jcmm.16350
    5. Yun Y, Song H, Ji Y, et al. Identification of therapeutic drugs against COVID-19 through computational investigation on drug repurposing and structural modification. J Biomed Res, 2020, 34(6): 458-469. DOI:10.7555/JBR.34.20200044
    6. Mascolo A, Urbanek K, De Angelis A, et al. Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?. Heart Fail Rev, 2020, 25(2): 367-380. DOI:10.1007/s10741-019-09837-7
    7. Alodhayani AA, Alkhushail A, Alhantoushi M, et al. Efficacy of treatment methods for uncontrolled hypertension and its effects on atrial fibrillation: A systematic narrative review. Int J Health Sci (Qassim), 2019, 13(6): 39-46.
    8. Omboni S, Volpe M. Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan. Adv Ther, 2019, 36(2): 278-297. DOI:10.1007/s12325-018-0859-x
    9. Aronow WS. Hypertension associated with atrial fibrillation. Ann Transl Med, 2017, 5(23): 457. DOI:10.21037/atm.2017.10.33

    Other cited types(0)

Catalog

    Article Metrics

    Article views (3552) PDF downloads (587) Cited by(9)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return